ArticleFrontiers in oncology2026

A novel prognostic signature based on mitochondrial permeability transition-driven necrosis genes for biochemical recurrence prediction in prostate cancer.

Xing Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.